Close Menu

Breaching the Barrier

With Veritas Genomics' announcement of its $999 whole genome sequencing, interpretation, and genetic counseling service, the Financial Times writes that 2016 looks like the year when the long-sought-after breach of the $1,000 genome-sequencing barrier is made. And this and other developments in the field, it says, could affect the development of personalized medicine.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.

Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.

In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.